This year's Futures National Conference, hosted by CureDuchenne for the Duchenne and Becker MD communities, is scheduled to ...

Columnist Shalom Lim celebrates two years of his relationship with reflections on life, love, and his experience with ...

It's been nearly two years since Elevidys, a gene therapy for Duchenne MD developed by Sarepta Therapeutics, was approved by ...

Columnist Patrick Moeschen highlights some key federal programs and pieces of legislation in the history of muscular ...

The FDA cleared Sarepta to start dosing in a first-in-human clinical trial testing the gene therapy SRP-9005 in people with LGMD type 2C.

After a primary care visit, columnist Robin Stemple faces a battery of tests and appointments, which he calls a medical merry ...

I have friends and family who seem to be living on a medical merry-go-round. Every day they go to doctor’s appointments, have medical tests, or go through therapy. Their lives revolve around their ...